Late Effects in the Era of Modern Therapy for Hodgkin Lymphoma

被引:83
作者
Hodgson, David C. [1 ,2 ]
机构
[1] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[2] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
CORONARY-ARTERY-DISEASE; BREAST-CANCER RISK; 2ND MALIGNANT NEOPLASMS; LONG-TERM SURVIVORS; RADIATION-THERAPY; CHILDHOOD-CANCER; MEDIASTINAL IRRADIATION; CARDIAC MORBIDITY; YOUNG-WOMEN; FOLLOW-UP;
D O I
10.1182/asheducation-2011.1.323
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Extended-field and subtotal nodal radiation therapy (RT), developed in the 1960s, was the first reliably curative treatment for early-stage Hodgkin lymphoma (HL). However, the large volume of normal tissue irradiated resulted in significant delayed toxicity, including cardiac disease and second cancers (SCs). The 30-year cumulative incidence of heart disease among adult survivors receiving 40-45 Gy of extended-field or mantle RT is approximately 30%; the incidence of SCs is similar. Improving disease control while reducing the toxicity of treatment has been a major objective of HL trials for more than 2 decades. Contemporary involved-field RT (IFRT) reduces irradiated volumes and produces significant reductions in normal tissue dose compared with historic treatments. Recent data indicate that, compared with mantle RT, IFRT reduces the relative risk of breast cancer among young females receiving mediastinal RT by approximately 60% and also reduces cardiac dose. The recent transition to involved-node RT allows further reductions in normal tissue dose. Response-adapted therapy is being evaluated in clinical trials as a means of identifying those patients most likely to benefit from treatment reduction or intensification, enhanced screening will facilitate early intervention to reduce the clinical burden of late effects, and there is increasing interest in elucidating the genetic correlates of treatment toxicity.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 46 条
[21]   Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer [J].
Hawkins, MM ;
Wilson, LMK ;
Burton, HS ;
Potok, MHN ;
Winter, DL ;
Marsden, HB ;
Stovall, MA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (05) :270-278
[22]   Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease [J].
Heidenreich, Paul A. ;
Schnittger, Ingela ;
Strauss, H. William ;
Vagelos, Randall H. ;
Lee, Byron K. ;
Mariscal, Carol S. ;
Tate, David J. ;
Horning, Sandra J. ;
Hoppe, Richard T. ;
Hancock, Steven L. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) :43-49
[23]   Radiation-induced cardiovascular injury [J].
Hendry, Jolyon H. ;
Akahoshi, M. ;
Wang, Li Sheng ;
Lipshultz, Steven E. ;
Stewart, Fiona A. ;
Trott, Klaus R. .
RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2008, 47 (02) :189-193
[24]   Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma [J].
Hodgson, David C. ;
Gilbert, Ethel S. ;
Dores, Grac A. M. ;
Schonfeld, Sara J. ;
Lynch, Charles F. ;
Storm, Hans ;
Hall, Per ;
Langmark, Froydis ;
Pukkala, Eero ;
Andersson, Michael ;
Kaijser, Magnus ;
Joensuu, Heikki ;
Foss, Sophie D. ;
Travis, Lois B. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1489-1497
[25]   Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy [J].
Hodgson, David C. ;
Pintille, Melan A. ;
Gitterman, Leah ;
DeWitt, Beth ;
Buckley, Carol-Ann ;
Ahmed, Sameera ;
Smith, Katherine ;
Schwartz, Amanda ;
Tsang, Rchard W. ;
Crump, Michael ;
Wells, Woodrow ;
Sun, Alexander ;
Gospoclarowicz, Man K. .
HEMATOLOGICAL ONCOLOGY, 2007, 25 (01) :11-15
[26]   Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy [J].
Hull, MC ;
Morris, CG ;
Pepine, CJ ;
Mendenhall, NP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (21) :2831-2837
[27]   Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study [J].
Inskip, Peter D. ;
Robison, Leslie L. ;
Stovall, Marilyn ;
Smith, Susan A. ;
Hammond, Sue ;
Mertens, Ann C. ;
Whitton, John A. ;
Diller, Lisa ;
Kenney, Lisa ;
Donaldson, Sarah S. ;
Meadows, Anna T. ;
Neglia, Joseph P. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) :3901-3907
[28]   Breast cancer after childhood cancer: A report from the childhood cancer survivor study [J].
Kenney, LB ;
Yasui, Y ;
Inskip, PD ;
Hammond, S ;
Neglia, JP ;
Mertens, AC ;
Meadows, AT ;
Friedman, D ;
Robison, LL ;
Diller, L .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (08) :590-597
[29]   Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease [J].
King, V ;
Constine, LS ;
Clark, D ;
Schwartz, RG ;
Muhs, AG ;
Henzler, M ;
Hutson, A ;
Rubin, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04) :881-889
[30]   A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk [J].
Koh, Eng-Siew ;
Tran, Tu Huan ;
Heydarian, Mostafa ;
Sachs, Rainer K. ;
Tsang, Richard W. ;
Brenner, David J. ;
Pintilie, Melania ;
Xu, Tony ;
Chung, June ;
Paul, Narinder ;
Hodgson, David C. .
RADIATION ONCOLOGY, 2007, 2 (1)